Let’s dive into some of the latest insights from Wall Street’s movers and shakers this Friday.
Evercore ISI continues to stand by Meta, maintaining a ‘buy’ rating. They’re seeing the stock as particularly enticing right now, especially after some recent government-induced market fluctuations. At $603 a share, which equates to 20 times the projected earnings for 2026, Meta is grabbing their attention as a compelling investment opportunity.
Over at Jefferies, Nike’s future looks bright as they also reiterate their ‘buy’ stance. As the leading brand in its market category, and with its valuation reverting to long-term averages, Jefferies advises investors to “Just Buy It.”
Needham, meanwhile, is optimistic about Robinhood, particularly with its expansion into prediction markets. They predict a $100 million annual revenue by 2025, despite the competitively lower margins due to promotional costs.
Switching gears to the gambling sector, BTIG has launched a ‘buy’ rating for Super Group Limited, setting sights on a $9 price target, citing potential upside for the shares.
In the entertainment landscape, Goldman Sachs is bullish about Sphere, freshly assigning it a ‘buy’ with aspirations of a 24% return over the next year, expecting the shares to inch up to $42.
Barclays has shifted its stance on Ferrari, upgrading it to ‘overweight.’ They’ve dubbed the luxury car maker a “safe haven,” highlighting Ferrari’s robust standing amidst European automotive uncertainties, and viewing the recent price correction as a prime opportunity to invest.
Goldman Sachs is optimistic about Tanger, revising its rating to ‘buy’ from neutral. They foresee the real estate investment trust continuing to impress with fund operations growth projected at 6.5% from 2025 through 2027.
Jefferies has upgraded Applied Materials to ‘buy,’ applauding its leadership in market share. With minimal exposure to China compared to its peers, it seems well-positioned against potential headwinds and stands to benefit from U.S. semiconductor trends.
However, not everything is rosy. Wells Fargo has downgraded Bausch + Lomb to ‘equal weight’ following a recall of its enVista product, citing the recall as a potential drag on short-term performance and investor sentiment.
Morgan Stanley has earmarked Cadence as a top pick, crediting the software company for its robust growth potential and enviable recurring revenue stream.
BMO has more faith in Check Point Software now, upgrading its rating to ‘outperform.’ They see durable growth on the horizon, driven by strategic investments and fresh leadership.
Bank of America remains in Disney’s corner, reiterating a ‘buy’ rating, taking macroeconomic uncertainties in stride without panic over the company’s core fundamentals.
JPMorgan keeps Netflix at an ‘overweight,’ highlighting interest in expanding its programming with significant “big events,” both domestically and internationally, possibly on a quarterly or monthly basis.
In the biotech space, Bank of America sees promise in Beam Therapeutics following its recent upgrade to ‘buy.’ The company’s innovative gene-editing platform, targeting rare diseases and cancers, offers a distinct edge in markets ripe with opportunity.
Raymond James has stepped back on Lululemon, now marking it as ‘market perform.’ Despite recent earnings reports, the projected growth didn’t quite meet expectations for the coming fiscal year.
Lastly, Deutsche Bank continues to support Tesla with a ‘buy’ rating even as they adjust the price target downward to $345 from $420. Despite recent pressures from lower car sales volumes and broader growth asset evaluations, Tesla’s journey is viewed as anything but straightforward, and future innovations are expected to be unpredictable and non-linear.
These insights offer a snapshot into the diverse opportunities and challenges as seen by financial experts, showcasing the rolling tides of today’s investment landscape.
